News from NORD

NORD and Neurology Reviews Publish Special Report


 

NORD and Neurology Reviews together have published the third annual Rare Neurological Disease Special Report in print and digital editions to promote awareness and understanding of rare neurological diseases among medical professionals. The publication includes articles on the efficacy of cannabis in treating children with rare and refractory epilepsy, delays in diagnosis and treatment of infantile spasms, telemedicine, new and potential therapies for rare neuromuscular disorders, and the clinical therapeutic potential of gene therapy.

Recommended Reading

Aplastic Anemia & MDS International Foundation Research Portal Is Open
Clinician Reviews
APS Type 1 Symposium Is Planned
Clinician Reviews
Foundation for Prader-Willi Research Highlights Study of Genetic Therapy for Prader-Willi Syndrome
Clinician Reviews
NORD Awards Grants for Rare Disease Research
Clinician Reviews
NORD Awards Grants for Rare Disease Research
Clinician Reviews
NORD Publishes Basic Principles for Health Coverage Reform
Clinician Reviews
NORD Submits Letter to Congress on Pre-Existing Conditions
Clinician Reviews
NORD Unveils “Do Your Share for Rare” Year-Long Awareness Campaign
Clinician Reviews
Tickets Now On Sale for NORD’s 2017 Rare Impact Awards
Clinician Reviews
NORD Announces Recipients of 2017 Rare Impact Awards
Clinician Reviews